SCHEMBL19084484

SCHEMBL19084484

C=C(C)/C=C(OCc1ccccc1)\C(C)=C/C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.47
HCAR2 Q8TDS4 1/20 0.39
TDP1 Q9NUW8 3/20 0.39
MAPK1 P28482 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A3 Q01959 1/20 0.39
KMT2A Q03164 1/20 0.39
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38
LMNA P02545 3/20 0.37
TSHR P16473 3/20 0.37
CYP3A4 P08684 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23899723 0.80 ALDH1A1 (0.53) ALDH1A1HCAR2TDP1MAPK1L3MBTL1
SCHEMBL17177756 0.77 ALDH1A1 (0.57) ALDH1A1HCAR2TDP1MAPK1L3MBTL1
SCHEMBL19901925 0.76 ALDH1A1 (0.48) ALDH1A1HCAR2TDP1MAPK1L3MBTL1
SCHEMBL6916614 0.74 ALDH1A1 (0.40) ALDH1A1HCAR2TDP1MAPK1L3MBTL1
SCHEMBL20371638 0.73 ALDH1A1 (0.46) ALDH1A1HCAR2TDP1MAPK1L3MBTL1
SCHEMBL156493 0.73 ALDH1A1 (0.63) ALDH1A1HCAR2TDP1MAPK1L3MBTL1
SCHEMBL873995 0.73 ALDH1A1 (0.63) ALDH1A1HCAR2TDP1MAPK1L3MBTL1
SCHEMBL4317881 0.73 ALDH1A1 (0.63) ALDH1A1HCAR2TDP1MAPK1L3MBTL1
SCHEMBL23788401 0.73 ALDH1A1 (0.53) ALDH1A1HCAR2TDP1MAPK1L3MBTL1
SCHEMBL873996 0.73 ALDH1A1 (0.63) ALDH1A1HCAR2TDP1MAPK1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170190715-A1 PYRIDINE DERIVATIVE ASTELLAS PHARMA INC. (JP) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170190715-A1 PYRIDINE DERIVATIVE LAP3, PREP, DNPEP ALDH1A1 360/4885HCAR2 435/4885TDP1 3910/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.